PanGen Biotech Inc. (KOSDAQ:222110)

PanGen Biotech Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 13, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	82,450	75,568	73,520	73,462	69,405	99,783
Market Cap Growth	29.14%	2.79%	0.08%	5.85%	-30.44%	1.96%
Enterprise Value	69,608	63,258	69,814	74,767	67,446	92,638
Last Close Price	6110.00	5600.00	5700.00	6880.00	6500.00	9350.00
PE Ratio	41.85	36.85	77.91	-	-	-
Forward PE	-	91.30	91.30	91.30	91.30	91.30
PS Ratio	6.15	5.63	5.01	10.04	10.68	12.57
PB Ratio	2.76	2.53	2.95	5.85	4.03	4.73
P/TBV Ratio	2.86	2.62	3.05	6.29	4.10	4.80
P/FCF Ratio	-	-	27.99	-	-	-
P/OCF Ratio	434.37	398.12	24.61	-	-	-
EV/Sales Ratio	5.19	4.72	4.76	10.22	10.38	11.67
EV/EBITDA Ratio	23.42	21.29	28.06	-	-	-
EV/EBIT Ratio	46.21	42.00	68.43	-	-	-
EV/FCF Ratio	-186.62	-	26.58	-	-	-
Debt / Equity Ratio	0.03	0.03	0.03	0.16	0	0.89
Debt / EBITDA Ratio	0.32	0.32	0.33	-	-	-
Debt / FCF Ratio	-	-	0.31	-	-	-
Net Debt / Equity Ratio	-0.43	-0.43	-0.43	0.14	-0.05	-0.26
Net Debt / EBITDA Ratio	-4.32	-4.32	-4.26	-0.69	0.28	3.08
Net Debt / FCF Ratio	34.43	34.43	-4.04	-0.47	0.20	1.14
Asset Turnover	0.42	0.42	0.57	0.35	0.20	0.20
Inventory Turnover	1.35	1.35	1.48	0.94	1.07	1.82
Quick Ratio	5.64	5.64	4.98	0.42	1.55	1.28
Current Ratio	8.43	8.43	7.16	1.72	7.59	1.57
Return on Equity (ROE)	7.48%	7.48%	5.04%	-30.14%	-23.46%	-18.75%
Return on Assets (ROA)	2.98%	2.98%	2.49%	-12.75%	-8.97%	-5.17%
Return on Invested Capital (ROIC)	8.59%	9.52%	6.69%	-27.46%	-28.62%	-22.21%
Return on Capital Employed (ROCE)	5.00%	5.00%	3.70%	-28.10%	-23.50%	-14.10%
Earnings Yield	2.49%	2.71%	1.28%	-6.11%	-6.48%	-3.32%
FCF Yield	-0.45%	-0.49%	3.57%	-5.27%	-6.10%	-4.76%
Buyback Yield / Dilution	-22.05%	-22.05%	-7.78%	-0.03%	-4.47%	-6.02%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.